Advanced Lab Technologies Core
Advanced Lab Technologies Core
批准号:
10238751
负责人:
Roger Keith Reeves
金额:
$35.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2024-07-31
关键词:
Acquired Immunodeficiency SyndromeAgingAreaBiocompatible MaterialsBostonCell Culture TechniquesCell SeparationCellsChIP-seqClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsColorCommunitiesComputer softwareComputing MethodologiesConfocal MicroscopyConsultationsContainmentContractsDana-Farber Cancer InstituteDataData SetDevelopmentDiseaseDoctor of PhilosophyEmerging TechnologiesEnsureEpigenetic ProcessEvaluationEvolutionFlow CytometryFluorescenceFosteringFundingGeneral HospitalsGenomicsGeographic DistributionGoalsGrantHIVHIV/TBHealthHospitalsHumanImageImage AnalysisImaging technologyImmune systemImmunologyIndividualInstitutesInstitutionIsraelLaboratoriesMassachusettsMedicalMedical centerMentorsMicroscopyMissionMolecularMolecular BiologyPediatric HospitalsPhenotypePlayProceduresProtocols documentationPublic Health SchoolsRecommendationResearchResearch DesignResearch PersonnelResolutionRoleSamplingScanningScienceServicesSiteSlideSorting - Cell MovementSpecimenStandardizationStructureTargeted ResequencingTechniquesTechnologyTherapeutic InterventionTimeTissue imagingTissuesTrainingUnited States National Institutes of HealthUniversitiesViralWomanbisulfite sequencingcareerco-infectiongenome wide methylationindexinginstrumentationmRNA sequencingmedical schoolsmembernew technologyonline communityperipheral bloodsymposiumsynergismtherapy developmenttooltraining opportunitytranscriptome sequencingtranscriptomicsvaccine developmentvirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Advanced Lab Technologies Core (Core I)
One of the greatest added values of the Harvard University (HU) CFAR has been accelerated member access
to new and emerging technologies. Science is accelerated by changes in technology, and the evolution of flow
cytometric, imaging and genomic techniques continues at a rapid pace. However, access to such technologies
and associated computational methodologies is an ever increasing and challenging barrier to individual
investigators. Acquisition and optimization of instrumentation and softwares and making them accessible
remains the primary focus of the HU CFAR Advanced Lab Technologies Core (ALTC). Making these cutting-
edge technologies available to HU CFAR users adds critically needed value to their studies of HIV reservoir
and cure, virus-host interactions, therapeutic interventions, and vaccine development. The consolidated ALTC
offers a unified pipeline of immunology services, molecular biology services, and training opportunities
strategically placed to serve the greater Harvard community at the most effective fiscal value. Indeed, the
ALTC serves hundreds of HU CFAR users and their global collaborators supported by more than 100 NIH-
funded grants/contracts across ten different NIH Institutes and Centers. The ALTC also continues to focus on
providing critical individualized technical support to Early Career Investigators (ECI), including dozens of HU
CFAR Developmental and Mentoring Core awardees. At the current time, much of the identified need for
members is in the capture of information regarding the phenotypic and functional state of individual cells,
indexing these samples, and then capitalizing on this precious biomaterial to develop a comprehensive picture
of the genomic landscape that exists in particular disease states. To ensure that all Harvard University CFAR
laboratories have access to this remarkable analytical power, this core will facilitate access to such
technologies through the following aims:
1) Provide HU CFAR member access to state-of-the art instrumentation and techniques.
2) Provide user training in all ALTC technologies, as well as computational assistance.
3) Build a virtual community using state of the art sharing and distribution tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:10408915
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10319735
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10408913
-
项目类别:
-
资助金额:$69.76万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10458737
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10305659
-
项目类别:
-
资助金额:$67.45万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10529270
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10626025
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
-
批准号:10451069
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
-
批准号:10408910
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
-
批准号:9927204
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
-
批准号:9405715
-
项目类别:
-
资助金额:$87.66万
-
财政年份:2017
-
负责人:Roger Keith Reeves
-
依托单位:
Advanced Technologies Core
-
批准号:9111795
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:9187130
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity
-
批准号:9117095
-
项目类别:
-
资助金额:$72.38万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:9316584
-
项目类别:
-
资助金额:$67.54万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Innate Lymphoid Cell Modulation of SIV Transmission and Pathogenesis
-
批准号:9089886
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and SIV Vaccines
-
批准号:9078188
-
项目类别:
-
资助金额:$71.7万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Enhancing Resolution of Memory NK cells in CMV- and SIV-infected macaques
-
批准号:9001899
-
项目类别:
-
资助金额:$16.59万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control
-
批准号:8509165
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2013
-
负责人:Roger Keith Reeves
-
依托单位:
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control
-
批准号:8607499
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2013
-
负责人:Roger Keith Reeves
-
依托单位:
海外基金